Literature DB >> 31486107

A propensity-score matched analysis of limb salvage vs amputation for osteosarcoma.

Sophia A Traven1, Daniel L Brinton1, Zeke J Walton1, Lee R Leddy1.   

Abstract

BACKGROUND AND OBJECTIVES: With recent advances in chemotherapy and surgical techniques, the trend in the treatment of osteosarcoma continues to progress towards limb salvage. However, studies comparing limb salvage with amputation continue to be limited by selection bias and small sample sizes. This study utilized propensity-score matching to minimize potential confounders and selection bias to compare the survival rates in patients with osteosarcoma that were treated with amputation vs limb salvage surgery.
METHODS: The Surveillance, Epidemiology, and End Results Program was utilized to identify all patients with a diagnosis of extremity osteosarcoma. Patients were matched with demographics, tumor characteristics, and treatment information. These variables were then fitted in a multivariate model and hazard ratios (HR) for overall- and disease-specific mortality was calculated.
RESULTS: A total of 4107 patients were identified, of which, 1538 were left after propensity-score matching. Older age, Black race, upper extremity location, and higher American joint committee on cancer (AJCC) class were associated with worse overall- and disease-specific mortality rates (P ≤ .0389). Compared with their matched counterparts, patients treated with amputation had higher overall mortality (HR 1.677; P < .0001) and higher disease-specific mortality (HR 1.678; P < .0001).
CONCLUSION: Patients whose tumor characteristics preclude limb salvage have significantly higher overall- and disease-specific mortality rates.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  amputation; limb salvage; mortality; osteosarcoma; surgery; survivorship

Mesh:

Year:  2019        PMID: 31486107     DOI: 10.1002/jso.25701

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  8 in total

1.  The Associations between Racial Disparities, Health Insurance, and the Use of Amputation as Treatment for Malignant Primary Bone Neoplasms in the US: A Retrospective Analysis from 1998 to 2016.

Authors:  Hans Lapica; Matan Ozery; Harsha Raju; Grettel Castro; Pura Rodriguez de la Vega; Noël C Barengo
Journal:  Int J Environ Res Public Health       Date:  2022-05-22       Impact factor: 4.614

2.  Elbow flexion reconstruction after arm-sparing excision for high-grade triton sarcoma: a case report.

Authors:  Elise Lupon; Christine Chevreau; Alexandre Gaston Lellouch; Dimitry Gangloff; Thomas Meresse
Journal:  J Med Case Rep       Date:  2020-07-04

3.  Limb-salvage surgery using personalized 3D-printed porous tantalum prosthesis for distal radial osteosarcoma: A case report.

Authors:  Ge Chen; Yiran Yin; Chang Chen
Journal:  Medicine (Baltimore)       Date:  2021-11-19       Impact factor: 1.889

4.  Risk stratification system and web-based nomogram constructed for predicting the overall survival of primary osteosarcoma patients after surgical resection.

Authors:  Bing Gao; Meng-Die Wang; Yanan Li; Fei Huang
Journal:  Front Public Health       Date:  2022-08-05

Review 5.  Current Status and Prospects of Clinical Treatment of Osteosarcoma.

Authors:  Zong-Yuan Jiang; Ji-Bin Liu; Xiao-Feng Wang; Yu-Shui Ma; Da Fu
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

6.  Outcomes of comprehensive treatment for primary osteosarcoma.

Authors:  Kazuhiko Hashimoto; Shunji Nishimura; Naohiro Oka; Masao Akagi
Journal:  SAGE Open Med       Date:  2020-05-20

7.  Limb salvage versus amputation in patients with osteosarcoma of the extremities: an update in the modern era using the National Cancer Database.

Authors:  Daniel R Evans; Alexander L Lazarides; Julia D Visgauss; Jason A Somarelli; Dan G Blazer; Brian E Brigman; William C Eward
Journal:  BMC Cancer       Date:  2020-10-14       Impact factor: 4.430

8.  Construction and Validation of Nomograms for Predicting the Prognosis of Juvenile Osteosarcoma: A Real-World Analysis in the SEER Database.

Authors:  Yao Jiang; Tianyu Wang; Zizheng Wei
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.